Sage Therapeutics Inc (SAGE)
14.00
+1.05
(+8.11%)
USD |
NASDAQ |
Apr 24, 16:00
14.00
0.00 (0.00%)
After-Hours: 20:00
Sage Therapeutics Cash and Short Term Investments (Quarterly): 753.18M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 753.18M |
| September 30, 2023 | 876.05M |
| June 30, 2023 | 1.003B |
| March 31, 2023 | 1.130B |
| December 31, 2022 | 1.272B |
| September 30, 2022 | 1.394B |
| June 30, 2022 | 1.514B |
| March 31, 2022 | 1.625B |
| December 31, 2021 | 1.742B |
| September 30, 2021 | 1.843B |
| June 30, 2021 | 1.911B |
| March 31, 2021 | 2.004B |
| December 31, 2020 | 2.100B |
| September 30, 2020 | 668.54M |
| June 30, 2020 | 756.52M |
| March 31, 2020 | 872.76M |
| December 31, 2019 | 1.008B |
| September 30, 2019 | 1.122B |
| June 30, 2019 | 1.237B |
| March 31, 2019 | 1.351B |
| December 31, 2018 | 922.78M |
| Date | Value |
|---|---|
| September 30, 2018 | 1.021B |
| June 30, 2018 | 1.092B |
| March 31, 2018 | 1.084B |
| December 31, 2017 | 518.85M |
| September 30, 2017 | 243.45M |
| June 30, 2017 | 285.93M |
| March 31, 2017 | 342.56M |
| December 31, 2016 | 397.48M |
| September 30, 2016 | 431.27M |
| June 30, 2016 | 272.30M |
| March 31, 2016 | 299.68M |
| December 31, 2015 | 186.75M |
| September 30, 2015 | 204.88M |
| June 30, 2015 | 224.23M |
| March 31, 2015 | 113.16M |
| December 31, 2014 | 127.77M |
| September 30, 2014 | 136.73M |
| June 30, 2014 | 49.13M |
| March 31, 2014 | 55.42M |
| December 31, 2013 | 8.066M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
668.54M
Minimum
Sep 2020
2.100B
Maximum
Dec 2020
1.307B
Average
1.237B
Median
Jun 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Biogen Inc | 1.050B |
| Perspective Therapeutics Inc | 9.238M |
| Vanda Pharmaceuticals Inc | 388.26M |
| ADMA Biologics Inc | 51.35M |
| Finch Therapeutics Group Inc | 25.12M |